A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Cutaneous Melanoma
Related studies linked through entity extraction aliases.
Proof of Concept of TBio-4101, Lymphodepleting Chemo, IL-2 for Relapsed/Refractory Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study of PF-08046049/SGN-BB228 in Advanced Melanoma and Other Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Olaparib in Unresectable/Metastatic Melanoma With BRCA1/2
- Status
- WITHDRAWN
- Phase
- PHASE2
Exercise to Boost Response to Checkpoint Blockade Immunotherapy
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- EARLY_PHASE1
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The MELAcare Study: A New Method for Surveillance of Melanoma Patients
- Status
- RECRUITING
- Phase
- NA
RTX-224 Monotherapy in Patients With Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Beta-only IL-2 ImmunoTherapY Study
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- Status
- RECRUITING
- Phase
- N/A
Safety and Preliminary Efficacy of MBS8(1V270) in Cancer Patients With Advanced Solid Tumours
- Status
- RECRUITING
- Phase
- PHASE1
Nemvaleukin Alfa Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Cutaneous or Mucosal Melanoma - ARTISTRY-6
- Status
- TERMINATED
- Phase
- PHASE2
Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome
- Status
- RECRUITING
- Phase
- N/A
Advanced Non-invasive Diagnostics for Early Cutaneous Tumor Diagnosis, Clinical-therapeutic and Economic Management
- Status
- COMPLETED
- Phase
- NA
Quality of Life, Lifestyle, and Psychosocial Factors in Patients With Melanoma
- Status
- RECRUITING
- Phase
- N/A
TH1902 in Patients With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1